Skip to main content
Top

08-03-2025 | Irritable Bowel Syndrome | Invited Commentary

It’s a Women’s World: A New Look at Sex Differences in Patients with the Irritable Bowel Syndrome

Authors: Madison R. Heath, Zlatan Mujagic, Yuying Luo, Daniel Keszthelyi

Published in: Digestive Diseases and Sciences

Login to get access

Abstract

Irritable bowel syndrome (IBS) exhibits significant sex differences. The female predominance in its worldwide prevalence and variations in symptomatology, treatment efficacy, and adverse effects all may arise from differences in pathophysiology. Due to entrenched historical biases, only recently have studies considered biological differences between the sexes that could affect the understanding of IBS. In this commentary, inspired by a study published in the Digestive Diseases and Sciences, the authors not only focus on different aspects of sexual dimorphism in IBS but also elaborate on the challenges that arise from studying female physiology and its temporal changes in relation to disease characteristics and treatment outcomes.
Literature
1.
go back to reference Olser W. The principles and practice of medicine. New York and London: D Appleton & Company. 1892. Olser W. The principles and practice of medicine. New York and London: D Appleton & Company. 1892.
2.
go back to reference Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:991–1000.CrossRefPubMed Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:991–1000.CrossRefPubMed
4.
go back to reference Abo S, Smith D, Stadt M et al. Modelling female physiology from head to Toe: impact of sex hormones, menstrual cycle, and pregnancy. J Theor Biol. 2022;7:111074.CrossRef Abo S, Smith D, Stadt M et al. Modelling female physiology from head to Toe: impact of sex hormones, menstrual cycle, and pregnancy. J Theor Biol. 2022;7:111074.CrossRef
6.
go back to reference Jacenik D, Krajewska WM. Significance of G protein-coupled estrogen receptor in the pathophysiology of irritable bowel syndrome, inflammatory bowel diseases and colorectal cancer. Front Endocrinol. 2020;12:11. Jacenik D, Krajewska WM. Significance of G protein-coupled estrogen receptor in the pathophysiology of irritable bowel syndrome, inflammatory bowel diseases and colorectal cancer. Front Endocrinol. 2020;12:11.
7.
go back to reference Melchior C, Wilpart K, Midenfjord I, et al. Relationship between Abuse history and gastrointestinal and extraintestinal symptom severity in irritable bowel syndrome. Biopsychosocial Science and Medicine. 2022;84 Melchior C, Wilpart K, Midenfjord I, et al. Relationship between Abuse history and gastrointestinal and extraintestinal symptom severity in irritable bowel syndrome. Biopsychosocial Science and Medicine. 2022;84
8.
go back to reference van Kessel L, Teunissen D, Lagro-Janssen T. Sex-gender differences in the effectiveness of treatment of irritable bowel syndrome: a systematic review. Int J Gen Med. 2021;14:867–884.CrossRefPubMedPubMedCentral van Kessel L, Teunissen D, Lagro-Janssen T. Sex-gender differences in the effectiveness of treatment of irritable bowel syndrome: a systematic review. Int J Gen Med. 2021;14:867–884.CrossRefPubMedPubMedCentral
9.
go back to reference Tack J, Schumacher K, Tonini G, et al. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS - PubMed. Gut. 2017;66. Tack J, Schumacher K, Tonini G, et al. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS - PubMed. Gut. 2017;66.
10.
go back to reference Farkouh A, Riedl T, Gottardi R et al. Sex-related differences in pharmacokinetics and pharmacodynamics of frequently prescribed drugs: a review of the literature. Adv Ther. 2020;37:644–655.CrossRefPubMed Farkouh A, Riedl T, Gottardi R et al. Sex-related differences in pharmacokinetics and pharmacodynamics of frequently prescribed drugs: a review of the literature. Adv Ther. 2020;37:644–655.CrossRefPubMed
Metadata
Title
It’s a Women’s World: A New Look at Sex Differences in Patients with the Irritable Bowel Syndrome
Authors
Madison R. Heath
Zlatan Mujagic
Yuying Luo
Daniel Keszthelyi
Publication date
08-03-2025
Publisher
Springer US
Published in
Digestive Diseases and Sciences
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-025-08965-5